Literature DB >> 6164427

Correlation between catecholamine secretion from bovine isolated chromaffin cells and [3H]-ouabain binding to plasma membranes.

D Aunis, A G García.   

Abstract

1 Secretion of catecholamines (CA) evoked by ouabain, chlormadinone acetate (CMA), phenoxybenzamine (Pbz) and vanadate, four agents known to inhibit Na(+), K(+)-dependent Mg(2+)-activated adenosine triphosphatase (ATPase) activity has been studied in suspensions of bovine isolated adrenal medullary cells.2 Acetylcholine (ACh) evoked a 5 fold increase of the basal CA secretion from isolated cells suspended in oxygenated Krebs-bicarbonate solution kept at 27 degrees C. Secretion was antagonized by Ca(2+)-deprivation or hexamethonium, indicating good functional viability of the cells.3 Ouabain (10(-7) to 10(-4) M) evoked a progressive, dose-dependent release of CA from cell suspensions. Study of the time course of the secretory response for 2 h allowed the separation of two components in the secretory response at all doses studied: a slow initial component (0.011 pg/min CA) and a second faster component (0.032 pg/min CA).4 CMA evoked a clear-cut CA secretory response. The ED(50) for CMA was 10(-4) M, as compared to 3 x 10(-6) M for ouabain. Pbz and vanadate did not induce CA release.5 [(3)H]-ouabain was taken up and bound to intact isolated cells by a non-saturable binding process. However, in semi-purified plasma membranes from bovine adrenal medulla a saturable specific [(3)H]-ouabain binding process was observed with a K(D) of 8.1 nM. Binding to the membranes was ATP-dependent and antagonized by K(+).6 [(3)H]-ouabain specific binding to membranes was antagonized by ouabain and CMA, but not by Pbz or vanadate; the ID(50) for ouabain and CMA were 10(-6) and 10(-5) M respectively.7 Ouabain partially inhibited, in a dose-dependent manner, Na(+), K(+)-Mg(2+) ATPase activity of the semi-purified plasma membranes.8 The results demonstrate a good correlation between the ability of different drugs, known to inhibit ATPase activity, to displace [(3)H]-ouabain binding to adreno-medullary plasma membranes and their capacity to evoke a CA secretory response from isolated chromaffin cells. The data also suggest that the CA secretory effects of ouabain may not be due simply to inhibition of the Na(+) pump and the subsequent ionic redistribution across the plasma membrane; a second mechanism may also be involved.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6164427      PMCID: PMC2071541          DOI: 10.1111/j.1476-5381.1981.tb09101.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

Review 1.  The role of Na+,K+-ATPase in the inotropic action of digitalis.

Authors:  T Akera; T M Brody
Journal:  Pharmacol Rev       Date:  1977-09       Impact factor: 25.468

Review 2.  Membrane adenosinetriphosphatase: a digitalis receptor?

Authors:  T Akera
Journal:  Science       Date:  1977-11-11       Impact factor: 47.728

3.  Stimulatory effect of vanadate on (Na+ + K+)-ATPase activity and on 3H-ouabain-binding in a cat heart cell membrane preparation.

Authors:  E Erdmann; W Krawietz; G Phillipp; I Hackbarth; W Schmitz; H Scholz
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

4.  Stimulation and inhibition of the sodium pump by cardioactive steroids in relation to their binding sites and their inotropic effect on guinea-pig isolated atria.

Authors:  J Ghysel-Burton; T Godfraind
Journal:  Br J Pharmacol       Date:  1979-06       Impact factor: 8.739

5.  Progesterone derivative binds to cardiac ouabain receptor and shows dissociation between sodium pump inhibition and increased contractile force.

Authors:  F S LaBella; I Bihler; R S Kim
Journal:  Nature       Date:  1979-04-05       Impact factor: 49.962

6.  The effect of ouabain on noradrenaline output from peripheral adrenergic neurones of isolated guinea-pig vas deferens.

Authors:  Y Nakazato; A Ohga; Y Onoda
Journal:  J Physiol       Date:  1978-05       Impact factor: 5.182

7.  The effect of ouabain on the secretion of catecholamines and on the intracellular concentration of potassium.

Authors:  P Banks
Journal:  J Physiol       Date:  1967-12       Impact factor: 5.182

8.  On the mechanism of release of norepinephrine from cat spleen slices by sodium deprivation and calcium pretreatment.

Authors:  A G Garcia; S M Kirpekar
Journal:  J Pharmacol Exp Ther       Date:  1975-02       Impact factor: 4.030

9.  Release of noradrenaline from the cat spleen by sodium deprivation.

Authors:  A G Garcia; S M Kirpekar
Journal:  Br J Pharmacol       Date:  1973-04       Impact factor: 8.739

10.  Vanadate is a potent (Na,K)-ATPase inhibitor found in ATP derived from muscle.

Authors:  L C Cantley; L Josephson; R Warner; M Yanagisawa; C Lechene; G Guidotti
Journal:  J Biol Chem       Date:  1977-11-10       Impact factor: 5.157

View more
  16 in total

1.  Brain soluble fractions which modulate Na+, K+-ATPase activity likewise modify muscarinic receptor.

Authors:  G Rodríguez de Lores Arnaiz; P Schneider; C Peña
Journal:  Neurochem Res       Date:  1999-11       Impact factor: 3.996

2.  The key role of sodium in the ouabain-mediated potentiation of potassium-evoked catecholamine release in cat adrenal glands.

Authors:  F J Abajo; M A Castro; P Sánchez-García
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

3.  Effects of Bay K 8644 on cat adrenal catecholamine secretory responses to A23187 or ouabain.

Authors:  C R Artalejo; A G Garcia
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

4.  Inhibition of Na+-pump enhances carbachol-induced influx of 45Ca2+ and secretion of catecholamines by elevation of cellular accumulation of 22Na+ in cultured bovine adrenal medullary cells.

Authors:  A Wada; H Takara; N Yanagihara; H Kobayashi; F Izumi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

5.  Effects of collagenase on the release of [3H]-noradrenaline from bovine cultured adrenal chromaffin cells.

Authors:  G Almazan; D Aunis; A G García; C Montiel; G P Nicolás; P Sánchez-García
Journal:  Br J Pharmacol       Date:  1984-04       Impact factor: 8.739

6.  Effects of the cardiotonic drug ARL-115 on the release of noradrenaline from the cat atrium, the binding of 3H-ouabain to plasma membranes and the movements of calcium in mitochondria.

Authors:  V Ceña; J Frias; A G García; M C Molinos; G P Nicolás; P Sánchez-García
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-09       Impact factor: 3.000

7.  Catecholamine release evoked by lithium from the perfused adrenal gland of the cat.

Authors:  F J Abajo; M A Castro; B Garijo; P Sánchez-García
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

8.  Facilitation of transmitter action on catecholamine output by cardiac glycoside in perfused adrenal gland of guinea-pig.

Authors:  Y Nakazato; A Ohga; Y Yamada
Journal:  J Physiol       Date:  1986-05       Impact factor: 5.182

9.  Ouabain distinguishes between nicotinic and muscarinic receptor-mediated catecholamine secretions in perfused adrenal glands of cat.

Authors:  Y Yamada; Y Nakazato; A Ohga
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

10.  Correlation between catecholamine release and sodium pump inhibition in the perfused adrenal gland of the cat.

Authors:  A G Garcia; E Garcia-Lopez; C Montiel; G P Nicolas; P Sanchez-Garcia
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.